Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medtronic PLC

93.67
-0.5400-0.57%
Post-market: 93.670.00000.00%19:58 EDT
Volume:4.31M
Turnover:404.21M
Market Cap:120.14B
PE:25.87
High:94.96
Open:94.42
Low:93.29
Close:94.21
52wk High:99.37
52wk Low:79.29
Shares:1.28B
Float Shares:1.28B
Volume Ratio:0.69
T/O Rate:0.34%
Dividend:2.81
Dividend Rate:3.00%
EPS(TTM):3.62
EPS(LYR):3.63
ROE:9.74%
ROA:4.57%
PB:2.51
PE(LYR):25.83

Loading ...

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

GlobeNewswire
·
Aug 12

Orchestra BioMed Receives FDA Approval for Expanded Patient Eligibility in BACKBEAT Global Pivotal Study

Reuters
·
Aug 08

Medtronic PLC Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 08

Orchestra BioMed Secures Over $111 Million in Strategic Financing Through Private Placement and Public Offering

Reuters
·
Aug 08

Medtronic plc to Announce Financial Results for First Quarter of Fiscal Year 2026

Reuters
·
Aug 06

Medtronic plc Announces Date for 2025 Annual General Meeting

Reuters
·
Aug 06

Bernstein Adjusts Price Target on Medtronic to $97 From $93, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Orchestra BioMed Secures $111 Million to Expand Clinical Programs and Advance AVIM and Virtue SAB Therapies

Reuters
·
Aug 05

BUZZ-Orchestra BioMed drops after $40 mln equity raise

Reuters
·
Aug 01

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra Biomed

THOMSON REUTERS
·
Aug 01

Orchestra Biomed: Ligand to Receive Low Double-Digit Royalty on First $100 Mln in Commercial REV From Orchestra's Avim Therapy, Virtue SAB Programs

THOMSON REUTERS
·
Aug 01

Orchestra BioMed Secures $70M Investment from Ligand and Medtronic for Cardiology Program Advancement

Reuters
·
Aug 01

BRIEF-Medtronic Considering Investment In Japanese Startups In Areas Such As AI, Nikkei Says

Reuters
·
Jul 31

Medtronic Considering Investment in Japanese Startups in Areas Such as Artificial Intelligence - Nikkei

THOMSON REUTERS
·
Jul 31

Medtronic plc Files Initial Statement of Beneficial Ownership for Michelle Quinn, EVP, GC and Secretary

Reuters
·
Jul 28

Medtronic Achieves Major Milestone in INFUSE™ Bone Graft Study, Prepares for FDA Premarket Approval Submission

Reuters
·
Jul 24

Boston Scientific lifts annual profit view on steady heart devices demand

Reuters
·
Jul 23

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

GlobeNewswire
·
Jul 21

BRIEF-Medtronic Secures CE Mark For Minimed 780G System

Reuters
·
Jul 21

Medtronic Receives CE Mark Approval to Expand Use of MiniMed™ 780G System for Children as Young as Two, During Pregnancy, and for Type 2 Diabetes in Europe

Reuters
·
Jul 21